We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+15.6%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$8.4B
AUM Growth
+$1.66B
Cap. Flow
+$1.33B
Cap. Flow %
15.85%
Top 10 Hldgs %
61.33%
Holding
510
New
182
Increased
113
Reduced
52
Closed
146

Top Buys

Rank Stock Value
1
AGIO icon
Agios Pharmaceuticals
AGIO
+$79.7M
2
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$74.4M
3
KVUE icon
Kenvue
KVUE
+$65.3M
4
ELF icon
e.l.f. Beauty
ELF
+$51.7M
5
GSK icon
GSK
GSK
+$46.6M

Top Sells

Rank Stock Value
1
TVTX icon
Travere Therapeutics
TVTX
+$96.3M
2
EXAS
Exact Sciences
EXAS
+$56.4M
3
PTCT icon
PTC Therapeutics
PTCT
+$34.5M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$28M
5
MDB icon
MongoDB
MDB
+$23M

Sector Composition

Rank Sector Weight
1 Healthcare 32.56%
2 Technology 5.44%
3 Consumer Discretionary 5.13%
4 Consumer Staples 2.69%
5 Communication Services 1.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HSY icon
426
Hershey
HSY
$36.7B
– –
-16,338
Closed -$3.06M
INVH icon
427
Invitation Homes
INVH
$18.1B
– –
-8,467
Closed -$248K
IPAR icon
428
Interparfums
IPAR
$3.84B
– –
-10,095
Closed -$993K
JBHT icon
429
JB Hunt Transport Services
JBHT
$25.2B
– –
-2,135
Closed -$286K
JD icon
430
JD.com
JD
$44.4B
– –
-103,400
Closed -$3.62M
JSPR icon
431
Jasper Therapeutics
JSPR
$22.6M
– –
-348,000
Closed -$828K
KAI icon
432
Kadant
KAI
$3.97B
– –
-725
Closed -$216K
KBE icon
433
State Street SPDR S&P Bank ETF
KBE
$1.66B
– –
-5,009
Closed -$298K
KEX icon
434
Kirby Corp
KEX
$6.94B
– –
-2,490
Closed -$208K
KMB icon
435
Kimberly-Clark
KMB
$36.2B
– –
-12,749
Closed -$1.59M
KMPR icon
436
Kemper
KMPR
$1.73B
– –
-5,801
Closed -$299K
LOGI icon
437
Logitech
LOGI
$15B
– –
-2,723
Closed -$299K
LUV icon
438
Southwest Airlines
LUV
$22.8B
– –
-10,302
Closed -$329K
LVS icon
439
Las Vegas Sands
LVS
$29.6B
– –
-3,729
Closed -$201K
MANH icon
440
Manhattan Associates
MANH
$11.4B
– –
-1,669
Closed -$342K
MDGL icon
441
CALL
Madrigal Pharmaceuticals
MDGL
$11.9B
– –
-130,000
Closed -$59.6M
MDU icon
442
MDU Resources
MDU
$4.3B
– –
-65,152
Closed -$1.16M
MELI icon
443
Mercado Libre
MELI
$91.5B
– –
-246
Closed -$575K
META icon
444
Meta Platforms (Facebook)
META
$1.52T
– –
-5,533
Closed -$4.06M
MGEE icon
445
MGE Energy Inc
MGEE
$3.06B
– –
-6,444
Closed -$542K
MHO icon
446
M/I Homes
MHO
$3.76B
– –
-1,665
Closed -$240K
MKC icon
447
McCormick & Company Non-Voting
MKC
$14.2B
– –
-17,147
Closed -$1.15M
MMS icon
448
Maximus
MMS
$3.16B
– –
-5,727
Closed -$523K
MOBX icon
449
Mobix Labs
MOBX
$25.7M
– –
-459,680
Closed -$3.71M
MPC icon
450
Marathon Petroleum
MPC
$84.4B
– –
-3,785
Closed -$730K
16 17
18
19 20

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q4 2025 Portfolio in Review

As of Q4 2025, Armistice Capital held 510 positions worth $8.4B, up 25% from $6.74B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Armistice Capital deployed $1.33B of net new capital in Q4 2025, opening 182 new positions and adding to 113 existing holdings. Its largest new stake was Kenvue: 3,992,196 shares worth $68.9M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Travere Therapeutics, an estimated $96.3M trimmed.

  • Armistice Capital's largest Q4 2025 buy was Kenvue: 3,992,196 shares worth $68.9M.
  • Armistice Capital added most to Agios Pharmaceuticals in Q4 2025, an estimated $79.7M increase.
  • Armistice Capital's biggest Q4 2025 reduction was Travere Therapeutics, cutting an estimated $96.3M.
  • Armistice Capital fully exited Exact Sciences in Q4 2025, selling an estimated $56.4M.
  • Armistice Capital's ten largest holdings make up 61% of its $8.4B portfolio in Q4 2025.
  • Armistice Capital opened 182 new positions and closed 146 in Q4 2025.
  • Armistice Capital's portfolio value rose 25% quarter-over-quarter to $8.4B.

Based on Armistice Capital's 13F filing for Q4 2025, filed 17 Feb 2026.